Cholesterol Explained offers clear, compassionate, and science-based guidance to help readers understand cholesterol, interpret test results, and navigate treatment options - from medications to lifestyle changes - in a simple yet accurate way. Written by two leading Australian cardiologists, it dispels myths, clarifies controversies, and presents evidence in a practical, accessible style to support confident, personalised decision-making. Whether newly diagnosed, managing long-term risk, or seeking a deeper understanding of heart health, this grounded resource emphasizes precision, evidence-aligned care for every individual.About the Author - Dr Warrick BishopDr Warrick Bishop is a practising cardiologist, best-selling author and keynote speaker, whose 'why' is to help people live as well as possible for as long as possible.He has a special interest in preventing heart attacks by using cardiac CT imaging, managing cholesterol, and paying attention to diet. He also supports patients through education as he believes that the best-educated patients receive the best healthcare. He enjoys a strong social media presence.Dr Bishop is the author of the books Know Your Real Risk of Heart Attack, Have You Planned Your Heart Attack?, Atrial Fibrillation Explained, Cardiac Failure Explained, Cardiac Rehabilitation Explained, and 10 Commandments of Heart Health Explained. He is also the founder and CEO of the Healthy Heart Network.About the Author - Dr Karam KostnerDr Karam Kostner is one of the most experienced lipidologists in Australia. He is an Associate Professor of Medicine at the University of Queensland and Director of Cardiology at Mater Public and Private Hospitals in Brisbane.He is also a director of Cholesterol Care Australia, a specialist cholesterol clinic and research facility in Brisbane, and a senior cardiologist with Heart of Australia, which delivers specialist healthcare services and testing to rural, remote, and indigenous communities across Queensland.His current clinical interests are preventive cardiology and lipid disorders. His passion combines helping people with high cholesterol and investigating new therapies.

Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease.  Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels. Despite this risk, awareness of Lp(a) is still very low among health care providers. Even cardiologists often overlook Lp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited.  This book offers an authoritative and comprehensive overview of Lipoprotein(a). It provides an in-depth review of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies.  Lipoprotein(a) is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.

Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease.  Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels. Despite this risk, awareness of Lp(a) is still very low among health care providers. Even cardiologists often overlook Lp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited. 

 

This book offers an authoritative and comprehensive overview of Lipoprotein(a). It provides an in-depth review of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies. 

 

Lipoprotein(a) is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.

Cholesterol Explained offers clear, compassionate, and science-based guidance to help readers understand cholesterol, interpret test results, and navigate treatment options - from medications to lifestyle changes - in a simple yet accurate way. Written by two leading Australian cardiologists, it dispels myths, clarifies controversies, and presents evidence in a practical, accessible style to support confident, personalised decision-making. Whether newly diagnosed, managing long-term risk, or seeking a deeper understanding of heart health, this grounded resource emphasizes precision, evidence-aligned care for every individual.About the Author - Dr Warrick BishopDr Warrick Bishop is a practising cardiologist, best-selling author and keynote speaker, whose 'why' is to help people live as well as possible for as long as possible.He has a special interest in preventing heart attacks by using cardiac CT imaging, managing cholesterol, and paying attention to diet. He also supports patients through education as he believes that the best-educated patients receive the best healthcare. He enjoys a strong social media presence.Dr Bishop is the author of the books Know Your Real Risk of Heart Attack, Have You Planned Your Heart Attack?, Atrial Fibrillation Explained, Cardiac Failure Explained, Cardiac Rehabilitation Explained, and 10 Commandments of Heart Health Explained. He is also the founder and CEO of the Healthy Heart Network.About the Author - Dr Karam KostnerDr Karam Kostner is one of the most experienced lipidologists in Australia. He is an Associate Professor of Medicine at the University of Queensland and Director of Cardiology at Mater Public and Private Hospitals in Brisbane.He is also a director of Cholesterol Care Australia, a specialist cholesterol clinic and research facility in Brisbane, and a senior cardiologist with Heart of Australia, which delivers specialist healthcare services and testing to rural, remote, and indigenous communities across Queensland.His current clinical interests are preventive cardiology and lipid disorders. His passion combines helping people with high cholesterol and investigating new therapies.

Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease.  Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels. Despite this risk, awareness of Lp(a) is still very low among health care providers. Even cardiologists often overlook Lp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited.  This book offers an authoritative and comprehensive overview of Lipoprotein(a). It provides an in-depth review of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies.  Lipoprotein(a) is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.

Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease.  Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels. Despite this risk, awareness of Lp(a) is still very low among health care providers. Even cardiologists often overlook Lp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited. 

 

This book offers an authoritative and comprehensive overview of Lipoprotein(a). It provides an in-depth review of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies. 

 

Lipoprotein(a) is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.